| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/03/2006 | US6982370 Cotton cultivar 01W93BR |
| 01/03/2006 | US6982368 Soybean cultivar 4803070 |
| 01/03/2006 | US6982367 Soybean cultivar 0509244 |
| 01/03/2006 | US6982366 Soybean cultivar 0509239 |
| 01/03/2006 | US6982365 Transgenic seed for generation and propagation of disease, drought, insect and freeze resistant plants; tissue engineering |
| 01/03/2006 | US6982364 Manipulation of a MinD gene in plants to alter plastid size, shape and/or number |
| 01/03/2006 | US6982362 for diagnosis/treatment of arteriosclerosis, diabetes; stem cells |
| 01/03/2006 | US6982361 Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal |
| 01/03/2006 | US6982327 Methods for producing and transforming cassava protoplasts |
| 01/03/2006 | US6982325 Gene encoding protein having aurone synthesizing activity |
| 01/03/2006 | US6982322 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip |
| 01/03/2006 | US6982320 Cytokine receptor common gamma chain like |
| 01/03/2006 | US6982319 Protein for use in the treatment of liver disorders, fibrosis, cancer, rheumatoid arthritis and glomeronephritis |
| 01/03/2006 | US6982318 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 01/03/2006 | US6982316 Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer |
| 01/03/2006 | US6982313 Genes and genetic elements associated with sensitivity to chemotherapeutic drugs |
| 01/03/2006 | US6982247 isolated peptide or protein of given sequence derived from the mucus of the foot sole of Archachatina marginata, a West-African snail; use against viral, bacterial or fungal infections |
| 01/03/2006 | US6982172 Oocyte vitrification technique |
| 01/03/2006 | US6982170 Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1 |
| 01/03/2006 | US6982169 Chemical inhibitors of mismatch repair |
| 01/03/2006 | US6982168 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer |
| 01/03/2006 | US6982165 spectroscopy; immobilization; comprises exposing single stranded DNA or RNA to exonuclease |
| 01/03/2006 | US6982162 Genetically engineered microorgaism for use as diagnostic tool |
| 01/03/2006 | US6982159 Trichoderma β-glucosidase |
| 01/03/2006 | US6982158 heating barley cell extracts in solution comprising magnesium and/or calcium to increase activity; phosphodiesterases; chromatography |
| 01/03/2006 | US6982149 Fiber array and methods for using and making same |
| 01/03/2006 | US6982148 Progressive elevated gene-3 (PEG-3) induces aggressive cancer phenotype and regulates angiogenesis |
| 01/03/2006 | US6982147 Apparatus for use in detecting preferential binding of probes to targets |
| 01/03/2006 | US6982145 contacting nucleus with radiation, crosslinking transcription factor to nucleic acid with formaldehyde |
| 01/03/2006 | US6982143 tagging; comprises dna polymerases/ribonucleases; kits |
| 01/03/2006 | US6982092 Method of complexing a nucleic acid with a lipid-conjugated polyamide |
| 01/03/2006 | US6982087 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 01/03/2006 | US6982086 Human immunodeficiency virus immunogenic composition |
| 01/03/2006 | US6982084 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies |
| 01/03/2006 | US6982083 Starch granules containing a recombinant polypeptide of interest, method for obtaining them, and their uses |
| 01/03/2006 | US6982082 Gene therapy by cell specific targeting |
| 01/03/2006 | CA2329510C Promoter sequence which is expressed in anthers and in pollen |
| 01/03/2006 | CA2261314C Frozen food with antifreeze peptides |
| 01/03/2006 | CA2176117C Generation of high titers of recombinant aav vectors |
| 01/03/2006 | CA2158937C Recombinant alphavirus vectors |
| 01/03/2006 | CA2070979C Sequence specific dna binding by p53 |
| 01/01/2006 | CA2502425A1 Allergen from house-dust mites |
| 12/29/2005 | WO2005124343A2 Methods for modulating bone tissue formation, orthogenic agents and pharmaceutical compositions |
| 12/29/2005 | WO2005124342A2 Methods and means for treatment of osteoarthritis |
| 12/29/2005 | WO2005124108A2 Reduced susceptibility towards pathogens, in particular comycetes, such as downy mildew in lettuce and spinach |
| 12/29/2005 | WO2005123993A2 Phage microarray profiling of the humoral response to disease |
| 12/29/2005 | WO2005123962A2 Gene targeting in eukaryotic cells by group ii intron ribonucleoprotein particles |
| 12/29/2005 | WO2005123960A1 Crude biological derivatives competent for nucleic acid detection |
| 12/29/2005 | WO2005123942A2 Analysis of methylated nucleic acid |
| 12/29/2005 | WO2005123937A2 Methods for expressing rnp particles in eukaryotic cells |
| 12/29/2005 | WO2005123936A1 Method of synthesizing polypeptide |
| 12/29/2005 | WO2005123935A1 Method of producing therapeutically useful product and system |
| 12/29/2005 | WO2005123931A1 System and method for electroporating a sample |
| 12/29/2005 | WO2005123930A1 Lentiviral vector |
| 12/29/2005 | WO2005123929A2 Plastid transit peptides |
| 12/29/2005 | WO2005123928A1 Production of human coagulation factor viii from plant cells and whole plants |
| 12/29/2005 | WO2005123927A1 Plants that produce amylopectin starch with novel properties |
| 12/29/2005 | WO2005123926A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of cytokinin oxydase in the seeds |
| 12/29/2005 | WO2005123925A1 Rnai-based method for selecting transfected eukaryotic cells |
| 12/29/2005 | WO2005123924A1 Method for cell surface display of target proteins using fadl of e. coli |
| 12/29/2005 | WO2005123923A2 Inducer specific tetracycline repressor proteins and methods of use thereof |
| 12/29/2005 | WO2005123922A1 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same |
| 12/29/2005 | WO2005123921A1 Novel glycerol dehydrogenase, gene therefor, and method of utilizing the same |
| 12/29/2005 | WO2005123920A1 Anther specific promoters and uses thereof |
| 12/29/2005 | WO2005123919A1 Plant polynucleotide promoter sequences from lolium festuca and arabidopsis |
| 12/29/2005 | WO2005123918A1 Expression vector capable of regulating the induction of foreign gene expression |
| 12/29/2005 | WO2005123917A1 Stabilized proline transporter |
| 12/29/2005 | WO2005123915A1 Stably maintained multiple copies of at least two orf in the same orientation |
| 12/29/2005 | WO2005123909A2 Isolation and characterization of muscle regenerating cells |
| 12/29/2005 | WO2005123773A1 Method for site-directed immunisation |
| 12/29/2005 | WO2005123766A2 Methods of making nanotechnological and macromolecular biomimetic structures |
| 12/29/2005 | WO2005123763A1 Production of polypeptides by improved secretion |
| 12/29/2005 | WO2005123242A1 Structural body, chip using the structural body, and method of controlling lyophilic/lyophobic properties |
| 12/29/2005 | WO2005123141A2 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent |
| 12/29/2005 | WO2005123117A1 Treatment of non alcoholic steatotic hepatitis (nash) |
| 12/29/2005 | WO2005122751A1 Nucleic acid molecules and their use in plant male sterility |
| 12/29/2005 | WO2005122750A2 Novel maize split-seed explant and methods for in vitro regeneration of maize |
| 12/29/2005 | WO2005122697A2 Transgenic plants containing a dehydrin gene |
| 12/29/2005 | WO2005122675A2 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proetins |
| 12/29/2005 | WO2005105995A3 RNA INTERFERENCE MEDIATED TREATMENT OF POLYGLUTAMINE (POLYQ) REPEAT EXPANSION DISEASES USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/29/2005 | WO2005103268A3 Generation of plants with altered oil content |
| 12/29/2005 | WO2005103229A3 Transgenomic mitochondria, transmitochondrial cells and organisms, and methods of making and using |
| 12/29/2005 | WO2005098009A3 Synergistic attenutation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 12/29/2005 | WO2005094370A3 Oligonucleotide complex compositions and methods of use as gene alteration tools |
| 12/29/2005 | WO2005086654A3 Self-cleaving affinity tags and methods of use |
| 12/29/2005 | WO2005074436A3 Self-assembling split-fluorescent protein systems |
| 12/29/2005 | WO2005072364A3 A modified baculovirus expression system for production of pseudotyped raav vector |
| 12/29/2005 | WO2005072270A3 Methods and compositons for treating cancer |
| 12/29/2005 | WO2005072092A3 Systems for tightly regulated gene expression |
| 12/29/2005 | WO2005069744A3 A simple low cost method and product for screening transgenic and non-transgenic plants from a large population either in field or green house |
| 12/29/2005 | WO2005066202A3 Bacillus cry9 family members |
| 12/29/2005 | WO2005065309A3 Lentiviral vector delivery of native and mutated igfbp-3 for treatment of cancer |
| 12/29/2005 | WO2005063802A3 Haemophilus influenzae type iv pili |
| 12/29/2005 | WO2005056578A3 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers |
| 12/29/2005 | WO2005053516A3 Replication competent hepatitis c virus and methods of use |
| 12/29/2005 | WO2005049790A3 Skn-1 and gsk-3 genes and proteins |
| 12/29/2005 | WO2005048943A3 Compositions and methods for synergistic induction of antitumor immunity |
| 12/29/2005 | WO2005045037B1 RNA INTERFERENCE MEDIATED INHIBITION OF 5-ALPHA REDUCTASE AND ANDROGEN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/29/2005 | WO2005042552A3 Modulation of sglt2 expression |
| 12/29/2005 | WO2005028650A3 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |